Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.45 |
| ▸ | NPY1R | P25929 | 5/20 | 0.45 |
| ▸ | NPY2R | P49146 | 4/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.40 |
| ▸ | NMT2 | O60551 | 2/20 | 0.40 |
| ▸ | NMT1 | P30419 | 2/20 | 0.40 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8010129 | 0.96 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL8010124 | 0.96 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30193233 | 0.95 | NMT1 (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30497050 | 0.94 | NOD1 (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31406583 | 0.94 | NOD1 (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30880861 | 0.94 | FOLH1 (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31343396 | 0.94 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL31343536 | 0.94 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29678655 | 0.94 | NMT1 (0.43) | NPY4RNPY1RNPY2RNPY5RNMT2 | |
| SCHEMBL29568549 | 0.93 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4172190-B1 | MODIFIED GELATINS | FUJIFILM CORP (JP) | 2025-01-29 | — | — | EP | disclosed |
| US-20230159623-A1 | MODIFIED GELATINS | FUJIFILM CORPORATION (JP) | 2023-05-25 | — | — | US | disclosed |
| EP-4172190-A1 | MODIFIED GELATINS | FUJIFILM Corporation (JP) | 2023-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159623-A1 | MODIFIED GELATINS | GLO1, GLMN, GYPA | NPY4R 3994/4885NPY1R 3439/4885NPY2R 3463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.